Patent Infringement: GSK moves court against Glenmark over Vilor F Medical Dialogues Team20 Nov 2021 4:51 PM ISTNew Delhi: Coming down on Glenmark Pharmaceuticals, British drug maker GlaxoSmithKline has filed a patent infringement case in the Delhi High Court...
Drug makers make progress tackling drug-resistant infections: AMF Ruchika Sharma18 Nov 2021 11:00 AM ISTNew Delhi: Drugmakers have made some progress in restraining antibiotics overuse, which leads to drug-resistant infections, but have fallen short in...
GSK Pharma net profit jumps over two-folds to Rs 204 crore in Q3 Ruchika Sharma31 Oct 2021 9:15 AM ISTNew Delhi: GlaxoSmithKline (GSK) Pharmaceuticals on friday posted an over two-fold increase in its consolidated net profit at Rs 204.24 crore for the...
Sanofi, GSK, Pfizer, Boehringer must face Zantac class-action lawsuits: Court Medical Dialogues Team16 Oct 2021 3:00 PM ISTNew Delhi: Rejecting the arguments by the branded drugmakers in the Zantac lawsuit, in a federal court in Florida, Judge Robin Rosenberg in separate...
GSK hails WHO recommendation for malaria vaccine rollout Medical Dialogues Bureau8 Oct 2021 5:58 PM ISTNew Delhi: In a significant development, in line with the recommendation of global advisory bodies for immunization and malaria, World Health...
GSK gets speedy USFDA nod for Jemperli Ruchika Sharma21 Aug 2021 11:00 AM ISTUK: GlaxoSmithKline (GSK) plc has recently announced that the US Food and Drug Administration (USFDA) approved a new indication for JEMPERLI...
GSK gets CDSCO marketing authorization for Rotavirus Vaccine, Live Attenuated, Oral IP Medical Dialogues Team20 Aug 2021 4:07 PM ISTNew Delhi: The pharmaceutical major, GlaxoSmithKline Pharmaceuticals Limited, has recently received a grant of marketing authorization for Rotavirus...
FDA approves Nucala as add-on treatment for chronic rhinosinusitis patients with nasal polyps Hina Zahid2 Aug 2021 9:00 AM ISTThe US Food and Drug Administration (FDA) has approved Nucala as a treatment for adults who have chronic rhinosinusitis with nasal polyps. Nucala...
Present clinical trial, pharmacokinetic data of antiparasitic drug Tafenoquine: CDSCO panel tells GSK Medical Dialogues Team31 July 2021 10:30 AM ISTNew Delhi: Seeking justification for Phase III Clinical Trial waiver, the Subject Expert Committee (SEC) functional under the Central Drug Standard...
GSK gets CDSCO panel okay for marketing Inactivated Influenza Vaccine for those above 64 Medical Dialogues Team12 July 2021 4:54 PM ISTNew Delhi: Granting the permission of local clinical trial waver, the Subject Expert Committee (SEC) of the Central Drugs Standard Control...
Sanofi, GSK get nod for late stage trial of Covid-19 vaccine in India Ruchika Sharma9 July 2021 1:21 PM ISTNew Delhi: Sanofi SA and GlaxoSmithKline Plc have received an approval from Indian authorities for a late-stage clinical trial of their...
GSK proposal for marketing Belimumab rejected by CDSCO panel Medical Dialogues Team8 July 2021 6:31 PM ISTNew Delhi: In a major setback to GlaxoSmithKline (GSK) Pharmaceuticals, the Subject Expert Committee (SEC) of the Central Drugs Standard Control...
